(CCLM) 43 (5), 470479
Why Do People Switch From Semaglutide to Tirzepatide The decision to change a weight loss medication is not a matter of mere preference
When used as medication, GLP-1 RAs increase insulin production when blood sugar is high, reduce the amount of glucagon (a hormone that raises blood sugar), slow digestion, and increase feelings of fullness
Peak plasma concentration (Cmax) occurs approximately 6090 minutes post-injection, coinciding with maximal MC1R occupancy in target tissues
Patients with diabetes taking Wegovy with an insulin or insulin secretagogue may have an increased risk of hypoglycemia, including severe hypoglycemia
Semaglutide (e.g., Ozempic, Wegovy) Mechanism: Semaglutide is a GLP-1 receptor agonist that mimics the hormone GLP-1, which regulates appetite and insulin levels